Plenty of IBD 50 names are showing resilience and holding near highs. Damaged charts are the exception, not the rule. That’s the good news. The bad news is that new buys aren’t easy to find for growth investors looking to put new money to work. A mild follow-through day for the Nasdaq on Aug. 13 has worked so far, but distribution days are starting to crop up.